Samsung Biologics to apply for Korea IPO approval on Aug 11 - bourse officials

Samsung Biologics to apply for Korea IPO approval on Aug 11 - bourse officials

A worker works on a Samsung outdoor advertisement installed atop an office building in central Seoul March 23, 2015. REUTERS/Kim Hong-Ji

Samsung Biologics Co Ltd, the biopharmaceutical contract manufacturing affiliate of Samsung Group, is expected to apply on August 11 for stock exchange approval of what is set to be South Korea’s biggest IPO this year, two bourse officials said.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter